Compare · HIND vs MDLN
HIND vs MDLN
Side-by-side comparison of Vyome Holdings Inc. (HIND) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HIND and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $51.35B, about 3356.3x HIND ($15.3M).
- Over the past year, HIND is down 81.7% and MDLN is down 5.5% - MDLN leads by 76.2 points.
- MDLN has been more active in the news (5 items in the past 4 weeks vs 1 for HIND).
- MDLN has more recent analyst coverage (25 ratings vs 0 for HIND).
PerformanceHIND-43.88%MDLN-5.46%
2025-12-17+0.00%2026-07-22
- Company
- Vyome Holdings Inc.
- Medline Inc.
- Price
- $2.20+0.92%
- $38.58-1.24%
- Market cap
- $15.3M
- $51.35B
- 1M return
- -1.35%
- +11.09%
- 1Y return
- -81.67%
- -5.46%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2016
- 2025
- News (4w)
- 1
- 5
- Recent ratings
- 0
- 25
Latest HIND
- Vyome Granted Chinese Patent Strengthening Immuno-Inflammation Portfolio
- Vyome Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-Q filed by Vyome Holdings Inc.
- Vyome Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Vyome Presents Transformational VT-1953 Phase 2 Clinical Study Data at Prestigious AACR 2026
- Vyome to Present Compelling Phase 2 Clinical Data on VT-1953 for Treatment of MFW at AACR 2026
- SEC Form DEF 14A filed by Vyome Holdings Inc.
- Vyome Reports Transformational 2025 Results: Company Well Positioned for Breakout Phase
- SEC Form PRE 14A filed by Vyome Holdings Inc.
- SEC Form 10-K filed by Vyome Holdings Inc.
Latest MDLN
- Medline strengthens California distribution network with new 1 million-square-foot facility in Perris
- Medline Inc. filed SEC Form 8-K: Leadership Update
- Medline announces Prime Vendor agreement with Allina Health
- Securing new 1.6-plus million square feet of new space after fire, Medline leases two large distribution centers in Northern California
- Medline to report second quarter 2026 results on August 5, 2026
- Officer Abrams William J covered exercise/tax liability with 1,308 shares, decreasing direct ownership by 7% to 16,546 units (SEC Form 4)
- Chief Human Resources Officer Shryock Christopher P covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Operating Officer Miller Stephen L covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Legal Officer Liberman Alexander M. covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Product Officer Laabs Amanda H. covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)